PPARG and obesity due to melanocortin 4 receptor deficiency: Furthermore, repression of PPARγ activity affects fat mobilization and may be a means to therapeutically treat obesity and extend lifespan7, and T0070907 has demonstrated efficacy in cancer models9–12.